The long-term goal of his research program is to identify molecular therapeutic targets for the development of new interventions to prevent or treat neuropsychiatric disorders, with a particular focus on affective disorders and related conditions. Research in his laboratory aims to further understand the underlying causes of such disorders, as well as assess the feasibility of novel treatment strategies.